Schizotypy provides a useful construct for understanding the development of schizophrenia
spectrum disorders. As research on the epidemiology of psychotic symptoms and clinical …

There is a growing body of evidence pointing to the co-occurrence of cannabis use and
depression. There is also some evidence that the use of cannabis may lead to the onset of …

The D2 dopamine receptor mediates neuropsychiatric symptoms and is a target of
pharmacotherapy. Inter-individual variation of D2 receptor density is thought to influence …

Opioid use in the United States has steadily risen since the 1990s, along with staggering
increases in addiction and overdose fatalities. With this surge in prescription and illicit opioid …

Both cannabis use and the dopamine receptor (DRD2) gene have been associated with
schizophrenia, psychosis-like experiences, and cognition. However, there are no published …

Schizotypal traits are of interest and importance in their own right and also have theoretical
and clinical associations with schizophrenia. These traits comprise attenuated psychotic …

Schizotypy refers to a constellation of personality traits that are believed to mirror the
subclinical expression of schizophrenia in the general population. Evidence from …

The human ability of identifying, processing and regulating emotions from social stimuli is
generally referred as Emotional Intelligence (EI). Within EI, Ability EI identifies a performance …

BackgroundSchizotypy is a putative risk phenotype for psychosis liability, but the overlap of
its genetic architecture with schizophrenia is poorly understood. MethodsWe tested the …

Alterations of the dopaminergic system may be important neurobiological correlates of
vulnerability and transition to psychosis. We systematically reviewed the evidence for …